Publikasi Scopus FKUI 2021 per tanggal 31 Maret 2021 (187 artikel)

Jamtani I., Nugroho A., Rahadiani N., Manangka R.S.W.
57220165203;57192888914;16426455700;57222276868;
Challenging retrovesical mass in men: Report of a rare liposarcoma case with concurrent COVID-19 infection
2021
BMJ Case Reports
14
3
e241466
Department of Surgery, Fatmawati Central General Hospital, Jakarta Selatan, DKI Jakarta, Indonesia; Anatomical Pathology Department, Faculty of Medicine, Universitas Indonesia/Cipto Mangunkusumo National Referral Hostpital, Jakarta, Indonesia; Radiology Department, Mayapada Hospital, DKI Jakarta, Indonesia
Jamtani, I., Department of Surgery, Fatmawati Central General Hospital, Jakarta Selatan, DKI Jakarta, Indonesia; Nugroho, A., Department of Surgery, Fatmawati Central General Hospital, Jakarta Selatan, DKI Jakarta, Indonesia; Rahadiani, N., Anatomical Pathology Department, Faculty of Medicine, Universitas Indonesia/Cipto Mangunkusumo National Referral Hostpital, Jakarta, Indonesia; Manangka, R.S.W., Radiology Department, Mayapada Hospital, DKI Jakarta, Indonesia
We describe a case of retrovesical liposarcoma in a male patient with concurrent COVID-19. A 50-year-old man had lower urinary tract symptoms and dull pain along his right gluteus. Due to COVID-19 infection, management was delayed. During self-isolation, the patient developed urinary retention and his pain level was an eight on the Visual Analogue Scale. A urinary catheter and an epidural catheter were inserted without any difficulty. Abdominal-pelvic MRI revealed a retrovesical mass suspected of liposarcoma with clear borders from surrounding organs. Following two consecutive negative SARS-CoV-2 PCR tests, we proceeded with surgery. Histopathology was dedifferentiated liposarcoma. Postoperatively, the patient suffered reactivation of COVID-19, and he was eventually discharged after two consecutive negative results on the PCR test on Post Operative Day (POD)-10. Retrovesical dedifferentiated liposarcoma is rare and considered as high-grade liposarcoma. Although surgery may exacerbate COVID-19 infection, surgical resection of symptomatic high-grade sarcoma is prioritised and performed as soon as no infection detected. ©
cancer intervention; COVID-19; pathology; radiology; surgery
adjuvant chemoradiotherapy; cancer grading; case report; dissection; human; isolation and purification; liposarcoma; lower urinary tract symptom; male; middle aged; nuclear magnetic resonance imaging; pathology; pathophysiology; pelvis tumor; procedures; surgery; therapy; time to treatment; treatment outcome; urine retention; Chemoradiotherapy, Adjuvant; COVID-19; Dissection; Humans; Liposarcoma; Lower Urinary Tract Symptoms; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Grading; Pelvic Neoplasms; SARS-CoV-2; Surgical Procedures, Operative; Time-to-Treatment; Treatment Outcome; Urinary Retention
BMJ Publishing Group
1757790X
33653868
Article
Q3
204
18269